Conjugated estrogen is an effective option to manage chronic GI bleeding in a patient with atrial fibrillation and end-stage renal disease

Authors

Matthew T. Compton, Wayne State UniversityFollow
Krupa Patel, University of Michigan, Ann ArborFollow

Abstract

A clinical decision report using:

Livio M, Mannucci PM, Viganò G, Mingardi G, Lombardi R, Mecca G, Remuzzi G. Conjugated estrogens for the management of bleeding associated with renal failure. N Engl J Med. 1986;315:731-735 https://doi.org/10.1056/NEJM198609183151204

for a patient with chronic GI bleeding and complicated pro- and anti-coagulation needs.

DOI

10.22237/crp/1622160660

Creative Commons License

This work is licensed under a Attribution 4.0 International (CC-BY 4.0) License

Recommended Citation

COMPTON MT, PATEL K. Conjugated estrogen is an effective option to manage chronic GI bleeding in a patient with atrial fibrillation and end-stage renal disease. Clin. Res. Prac. Jun 29 2021;7(1):eP2753. https://doi.org/10.22237/crp/1622160660